These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34686499)

  • 1. Activation of
    Biran A; Yin S; Kretzmer H; Ten Hacken E; Parvin S; Lucas F; Uduman M; Gutierrez C; Dangle N; Billington L; Regis FF; Rassenti LZ; Mohammad A; Hoffmann GB; Stevenson K; Zheng M; Witten E; Fernandes SM; Tausch E; Sun C; Stilgenbauer S; Brown JR; Kipps TJ; Aster JC; Gnirke A; Neuberg DS; Letai A; Wang L; Carrasco RD; Meissner A; Wu CJ
    Cancer Res; 2021 Dec; 81(24):6117-6130. PubMed ID: 34686499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis.
    Böttcher M; Bruns H; Völkl S; Lu J; Chartomatsidou E; Papakonstantinou N; Mentz K; Büttner-Herold M; Zenz T; Herling M; Huber W; Ghia P; Stamatopoulos K; Mackensen A; Mougiakakos D
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia.
    Shukla V; Shukla A; Joshi SS; Lu R
    Oncotarget; 2016 Jul; 7(27):41081-41094. PubMed ID: 27232759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.
    Sharma S; Pavlasova GM; Seda V; Cerna KA; Vojackova E; Filip D; Ondrisova L; Sandova V; Kostalova L; Zeni PF; Borsky M; Oppelt J; Liskova K; Kren L; Janikova A; Pospisilova S; Fernandes SM; Shehata M; Rassenti LZ; Jaeger U; Doubek M; Davids MS; Brown JR; Mayer J; Kipps TJ; Mraz M
    Blood; 2021 May; 137(18):2481-2494. PubMed ID: 33171493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells.
    Boudny M; Zemanova J; Khirsariya P; Borsky M; Verner J; Cerna J; Oltova A; Seda V; Mraz M; Jaros J; Jaskova Z; Spunarova M; Brychtova Y; Soucek K; Drapela S; Kasparkova M; Mayer J; Paruch K; Trbusek M
    Haematologica; 2019 Dec; 104(12):2443-2455. PubMed ID: 30975914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells.
    Rosati E; Sabatini R; Rampino G; Tabilio A; Di Ianni M; Fettucciari K; Bartoli A; Coaccioli S; Screpanti I; Marconi P
    Blood; 2009 Jan; 113(4):856-65. PubMed ID: 18796623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eμ-TCL1xMyc: A Novel Mouse Model for Concurrent CLL and B-Cell Lymphoma.
    Lucas F; Rogers KA; Harrington BK; Pan A; Yu L; Breitbach J; Bundschuh R; Goettl VM; Hing ZA; Kanga P; Mantel R; Sampath D; Smith LL; Wasmuth R; White DK; Yan P; Byrd JC; Lapalombella R; Woyach JA
    Clin Cancer Res; 2019 Oct; 25(20):6260-6273. PubMed ID: 31296529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle.
    Caraballo JM; Acosta JC; Cortés MA; Albajar M; Gómez-Casares MT; Batlle-López A; Cuadrado MA; Onaindia A; Bretones G; Llorca J; Piris MA; Colomer D; León J
    Oncotarget; 2014 Jul; 5(13):4694-708. PubMed ID: 25051361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SENP2 exerts an anti‑tumor effect on chronic lymphocytic leukemia cells through the inhibition of the Notch and NF‑κB signaling pathways.
    Chen XL; Wang SF; Liang XT; Liang HX; Wang TT; Wu SQ; Qiu ZJ; Zhan R; Xu ZS
    Int J Oncol; 2019 Feb; 54(2):455-466. PubMed ID: 30431078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas.
    Ryan RJH; Petrovic J; Rausch DM; Zhou Y; Lareau CA; Kluk MJ; Christie AL; Lee WY; Tarjan DR; Guo B; Donohue LKH; Gillespie SM; Nardi V; Hochberg EP; Blacklow SC; Weinstock DM; Faryabi RB; Bernstein BE; Aster JC; Pear WS
    Cell Rep; 2017 Oct; 21(3):784-797. PubMed ID: 29045844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent effects of Dnmt3a in an inducible murine model of Kras
    Rogers JH; Rosen A; Reyes JM; Ketkar S; Conneely SE; Gupta R; Yang L; Miller MB; Medrano G; Aguilar R; Uchenda N; Goodell MA; Rau RE
    Exp Hematol; 2024 Jul; 135():104248. PubMed ID: 38834136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Notch signal pathway and chronic lymphocytic leukemia].
    Zhang JY; Xu ZS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1472-5. PubMed ID: 25338610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation.
    Rosati E; Sabatini R; De Falco F; Del Papa B; Falzetti F; Di Ianni M; Cavalli L; Fettucciari K; Bartoli A; Screpanti I; Marconi P
    Int J Cancer; 2013 Apr; 132(8):1940-53. PubMed ID: 23001755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model.
    Chiang CL; Goswami S; Frissora FW; Xie Z; Yan PS; Bundschuh R; Walker LA; Huang X; Mani R; Mo XM; Baskar S; Rader C; Phelps MA; Marcucci G; Byrd JC; Lee LJ; Muthusamy N
    Blood; 2019 Aug; 134(5):432-444. PubMed ID: 31151986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells.
    Wilmore S; Rogers-Broadway KR; Taylor J; Lemm E; Fell R; Stevenson FK; Forconi F; Steele AJ; Coldwell M; Packham G; Yeomans A
    Cell Mol Life Sci; 2021 Sep; 78(17-18):6337-6349. PubMed ID: 34398253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch signaling promotes disease initiation and progression in murine chronic lymphocytic leukemia.
    Tardivon D; Antoszewski M; Zangger N; Nkosi M; Sordet-Dessimoz J; Hendriks R; Koch U; Radtke F
    Blood; 2021 Jun; 137(22):3079-3092. PubMed ID: 33512383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia.
    Xiong H; Mancini M; Gobert M; Shen S; Furtado GC; Lira SA; Parkhurst CN; Garambois V; Brengues M; Tadokoro CE; Trimarchi T; Gómez-López G; Singh A; Khiabanian H; Minuzzo S; Indraccolo S; Lobry C; Aifantis I; Herranz D; Lafaille JJ; Maraver A
    Theranostics; 2021; 11(4):1594-1608. PubMed ID: 33408769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL.
    Hubmann R; Schnabl S; Araghi M; Schmidl C; Rendeiro AF; Hilgarth M; Demirtas D; Ali F; Staber PB; Valent P; Zielinski C; Jäger U; Shehata M
    Cells; 2020 Jun; 9(6):. PubMed ID: 32570839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRF4 L116R mutation promotes proliferation of chronic lymphocytic leukemia B cells inducing MYC.
    Benatti S; Atene CG; Fiorcari S; Mesini N; Martinelli S; Zucchini P; Bacchelli F; Maccaferri M; Debbia G; Potenza L; Rossi D; Vallisa D; Trentin L; Gaidano G; Luppi M; Marasca R; Maffei R
    Hematol Oncol; 2021 Dec; 39(5):707-711. PubMed ID: 34431535
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia.
    Rivas JR; Liu Y; Alhakeem SS; Eckenrode JM; Marti F; Collard JP; Zhang Y; Shaaban KA; Muthusamy N; Hildebrandt GC; Fleischman RA; Chen L; Thorson JS; Leggas M; Bondada S
    Leukemia; 2021 Nov; 35(11):3188-3200. PubMed ID: 33731852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.